Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
Authors:
- Virendra SinghVSVirendra Singh
- Souvik GhoshSGSouvik Ghosh
- Baljinder SinghBSBaljinder Singh
- Pradeep KumarPKPradeep Kumar
- Navneet SharmaNSNavneet Sharma
- Ashish BhallaABAshish Bhalla
- A.K. SharmaASA.K. Sharma
- N.S. ChoudharyNCN.S. Choudhary
- Yogesh ChawlaYCYogesh Chawla
- C.K. NainCNC.K. Nain
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 56 (6) , 1293-1298
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized StudyGastroenterology, 2008
- A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal SyndromeGastroenterology, 2008
- Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot studyJournal of Hepatology, 2007
- Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascitesJournal of Hepatology, 2007
- Noradrenaline and albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: a randomized pilot studyJournal of Internal Medicine, 2006
- Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: A randomized studyJournal of Gastroenterology and Hepatology, 2006
- Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysisJournal of Hepatology, 2005
- Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized studyHepatology, 2002
- Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot studyHepatology, 2002
- New challenge of hepatorenal syndrome: Prevention and treatmentHepatology, 2001